Axe Compute Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Axe Compute Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $797.7K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $1.02M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.00M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $933.7K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $805.1K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $879.8K | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $995.9K | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $506.8K | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $274.9K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $350.4K | Mar 15, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($233.10M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($12.66M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($13.98M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($25.74M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($19.66M) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($25.88M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($19.39M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($10.09M) | Apr 1, 2020 |
| FY2014 | Dec 31, 2014 | ($6.83M) | Apr 30, 2015 |
| FY2014 | Dec 31, 2013 | ($9.41M) | Apr 30, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($180.92M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($10.30M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($12.12M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($26.03M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($20.43M) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($25.36M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($22.64M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($7.86M) | Apr 1, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.24M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $122.3K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $320.3K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $315.9K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $372.7K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $423.0K | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $526.3K | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $289.0K | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $406.0K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($13.19M) | Mar 28, 2024 |
| FY2023 | Dec 31, 2022 | ($12.37M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($12.21M) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($12.26M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($8.73M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($5.29M) | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | ($4.46M) | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | ($4.38M) | Apr 2, 2018 |
| FY2012 | Dec 31, 2012 | ($1.18M) | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | ($1.78M) | Mar 22, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.5K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $21.5K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $419.9K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $910.4K | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $298.4K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $5.9K | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $177.7K | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $45.1K | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $32.8K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.89M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.97M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.42M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $25.73M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $43.77M | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $13.06M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $22.38M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.71M | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $3.62M | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $2.81M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.17M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.18M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.15M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $3.97M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.51M | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $10.42M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $11.14M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.66M | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $932.3K | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $1.88M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.72M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($202.6K) | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | $1.97M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $8.27M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $21.77M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $40.27M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.64M | Mar 21, 2023 |
| FY2021 | Dec 31, 2019 | $11.23M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $53.5K | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $2.69M | Apr 1, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 21, 2023 |
| FY2022 | Dec 31, 2021 | $6.86M | Mar 21, 2023 |
| FY2022 | Dec 31, 2020 | $2.81M | Mar 21, 2023 |
| FY2021 | Dec 31, 2019 | $15.69M | Mar 31, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($413.52M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($180.43M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($167.76M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($153.78M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($128.04M) | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | ($108.38M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($82.50M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($63.11M) | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | ($53.02M) | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | ($47.02M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $611.8K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $8.73M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $22.07M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $28.20M | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | $678.3K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $150.8K | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $162.2K | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | $766.2K | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | $1.76M | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Mar 31, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (13) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (34) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (6) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 21, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 444,475 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 4.06M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 3.94M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 65.61M | Mar 21, 2023 |
| FY2021 | Dec 31, 2020 | 19.80M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 4.06M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | 1.41M | Apr 1, 2020 |
| FY2018 | Dec 31, 2017 | 6.94M | Apr 2, 2019 |
| FY2017 | Dec 31, 2016 | 4.56M | Apr 2, 2018 |